معرفی
Steven Young-Min is a researcher specializing in rheumatology, with a focus on autoimmune conditions such as primary Sjögren's syndrome and rheumatoid arthritis. His work involves biomarker discovery, genetic associations, disease progression, and patient-reported outcomes, often in collaboration with large UK-based research consortia like BRAGGSS. Although his current institutional affiliation is not explicitly stated, his long-standing contributions to clinical and translational research in rheumatology suggest a strong academic presence.
- PhD in Rheumatology or related field (inferred from research depth)
- Extensive collaboration with UK rheumatology research networks
- Active in clinical and genetic studies from 2001–2017
His research interests center on understanding the mechanisms of fatigue, dryness symptoms, radiographic progression, and treatment response in autoimmune diseases. He has investigated the role of cytokines, matrix metalloproteinases, and genetic polymorphisms in disease activity and outcomes. His work bridges clinical observation with molecular and genetic analysis to improve patient stratification and therapeutic efficacy.
The 15 most recent publications reflect a consistent focus on primary Sjögren's syndrome and rheumatoid arthritis, with increasing emphasis on genetic and transcriptional biomarkers, patient-reported outcomes, and treatment monitoring. Key themes include the discordance between subjective and objective disease measures, the utility of biomarkers in predicting progression, and the impact of psychological and autonomic factors on symptom burden.
No scientific awards are mentioned in the provided text.
There is no information available about student advising or research grants. However, his participation in large collaborative studies such as BRAGGSS indicates involvement in funded research programs. His work on genetic associations and treatment response suggests leadership or significant contribution to multicenter projects.
While no specific lab or research team is named, his repeated collaborations with groups studying rheumatoid arthritis genetics (e.g., BRAGGSS) and Sjögren's syndrome registries imply active membership in established research networks focused on autoimmune disease mechanisms and outcomes.
